期刊文献+

抗病毒口服液的质量标准改进研究 被引量:4

Research on Quality Improvement of Antiviral Oral Liquid
下载PDF
导出
摘要 目的:提高抗病毒口服液的质量标准。方法:采用高效液相色谱法测定抗病毒口服液中(R,S)-告依春、连翘酯苷A和连翘苷的含量,并同时建立抗病毒口服液的指纹图谱。色谱柱为Waters CORTECS C_(18)柱(150 mm×4.6 mm,2.7μm);流动相为甲醇-0.1%磷酸溶液,梯度洗脱;检测波长为236 nm;柱温为29℃。结果:(R,S)-告依春、连翘酯苷A及连翘苷分别在16.86~527.00、156.43~4 888.50及122.97~3 842.85 ng范围内与相应峰面积呈良好的线性关系。(R,S)-告依春、连翘酯苷A及连翘苷的平均加样回收率分别为89.9%(RSD=2.9%)、93.5%(RSD=3.6%)及95.1%(RSD=0.8%)。建立了抗病毒口服液的高效液相指纹图谱共有模式,标定了其中9个共有峰,40批抗病毒口服液的相似度均>0.9。结论:该含量测定方法简便、准确,专属性强,结合特征性强的高效液相指纹图谱可更好地控制抗病毒口服液的质量。 OBJECTIVE: To improve the quality standard of antiviral oral liquid. METHODS: High performance liquid chromatography( HPLC) was adopted to determine the content of( R,S)-epigoitrin,forsythoside A and forsythin,in the meantime,finger-print of antiviral oral liquid was also established. With the chromatographic column was Waters CORTECS C_(18)( 150 mm × 4. 6 mm,2. 7 μm); the mobile phase was methyl alcohol -0. 1% of phosphoric acid solution,with gradient elute; the detected wave length was 236 nm; and the column temperature was 29 ℃.RESULTS:( R,S)-epigoitrin,forsythoside A and forsythin presented well linear relation with their corresponding peak areas in respective ranges of 16. 86-527. 00 ng,156. 43-4 888. 50 ng and 122. 97-3 842. 85 ng. The average sampleadding recovery rates of( R,S)-epigoitrin,forsythoside A and forsythin were respectively 89. 9%( RSD = 2. 9%),93. 5%( RSD = 3. 6%) and 95. 1%( RSD = 0. 8%). Under the establishment of mutual model of HPLC finger-print of antiviral oral liquid,a total of 9 mutual peaks were marked,the similarity of 40 batches of antiviral oral liquid was 〉0. 9. CONCLUSIONS: This content-determination method is convenient and accurate,with strong specificity,which can preferably control the quality of antiviral oral liquid with the combination of HPLC finger-print.
作者 邱陈劲 孟鹤 谢小燕 刘潇潇 陈佩文 杨志业 QIU Chenjin;MENG He;XIE Xiaoyan;LIU Xiaoxiao;CHEN Peiwen;YANG Zhiye(Traditional Chinese Medicine Chamber,Guangdong Institute for Food and Drug Control,Guangdong Guangzhou 510180,China;Dept.of Research and Development,Xiangxue Pharmaceutial Co.,Ltd,Guangdong Guangzhou 510530,China)
出处 《中国医院用药评价与分析》 2018年第7期870-873,875,共5页 Evaluation and Analysis of Drug-use in Hospitals of China
基金 广东省中医药局科研项目(No.20171040)
关键词 抗病毒口服液 高效液相 指纹图谱 Antiviral oral liquid HPLC Finger-print
  • 相关文献

参考文献16

二级参考文献156

共引文献246

同被引文献83

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部